UncategorizedCellProthera publishes Phase I/IIb trial in JACC: Heart Failure – Longevity.Technology Empower Meds / September 25, 2025
UncategorizedRapamycin Longevity Lab adds leading scientists to its mission Empower Meds / September 24, 2025
UncategorizedFirst Parkinson’s patient treated in BlueRock Phase III trial – Longevity.Technology Empower Meds / September 24, 2025
UncategorizedMenopause care expands across New York with Elektra Health’s insurance coverage – Longevity.Technology Empower Meds / September 24, 2025
UncategorizedCharacter Biosciences named among Fierce 15 biotech firms of 2025 – Longevity.Technology Empower Meds / September 24, 2025
UncategorizedInBrain Pharma to present long-term DIVE-I data at MDS 2025 – Longevity.Technology Empower Meds / September 24, 2025
UncategorizedCerevance to present Phase 2 solengepras data at Parkinson’s congress – Longevity.Technology Empower Meds / September 24, 2025
